Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 3, 1996

View Archived Issues

Merck reveals new thrombin inhibitor series

New farnesyl protein transferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

Pharmacopeia reports protein farnesyl transferase inhibitors

COX-2 inhibitors under investigation at Glaxo Wellcome

RPR claims dual-action TNF/cAMP phosphodiesterase inhibitors

New hope for muscular dystrophy sufferers

New hope for heart failure patients

Cathepsin B and L inhibitors described by Nippon Chemiphar

Apotex opens export-dedicated pharmaceutical facility

Avonex progresses toward European approval

Merger creates new medical device company

Millipore to acquire business from W.R. Grace

Osiris licenses inducing molecule involved in cartilage formation

New tamoxifen combination effective against metastatic solid tumors

New treatment options improve outlook for patients with viral skin infections

Aquaphore ointment protects premature infants from dermatological infections

Treatment options for photodamaged skin

Enhanced chemotherapeutic efficacy reported for amsalog combination

Once-daily antihypertensive combination cleared for marketing in Canada

Novel antiobesity drug filed for approval

AADA filed for generic ciclosporin

Pulmozyme cleared for advanced CF

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...